InvestorsHub Logo
Followers 57
Posts 11404
Boards Moderated 0
Alias Born 02/09/2009

Re: haysaw post# 23740

Thursday, 11/12/2015 9:24:02 AM

Thursday, November 12, 2015 9:24:02 AM

Post# of 30990
If you had seen what I have seen you would think twice before rejecting positive views as "bias."

Please read this carefully, do a bit of research on the connections of NF-kB and inflammation with a long list of diseases, then ask yourself if people who benefited from anatabine citrate were necessarily just imagining things.

http://investors.rockcreekpharmaceuticals.com/index.php?s=43&item=212

About Anatabine Citrate:
Rock Creek Pharmaceuticals' compound is a small molecule, cholinergic agonist that exhibits anti-inflammatory pharmacological characteristics, distinct from other anti-inflammatory drugs available such as biologics, steroids and non-steroidal anti-inflammatories. The Company has sponsored extensive pre-clinical (in vitro and in vivo) studies resulting in peer reviewed and published scientific journal articles, covering models of Multiple Sclerosis, Alzheimer's Disease, and Auto-Immune Thyroiditis. All these studies demonstrated the anti-inflammatory effects of the Company's compound.

Pay close attention to "cholinergic agonist" - it's important. Notice what drugs anatabine citrate might displace (in part or whole) in the market: "biologics, steroids and non-steroidal anti-inflammatories." This may be important too. It might explain a lot of what has happened.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.